Carboplatin, Methotrexate and 5-Fluorouracil in Combination with Medroxyprogesterone Acetate (JMF-M) in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Hellenic Cooperative Oncology Group Study

D. Bafaloukos,G. Aravantinos,George Samonis,G. Katsifis,C. Bakoyiannis,D. Skarlos,P. Kosmidis

Carboplatin, Methotrexate and 5-Fluorouracil in Combination with Medroxyprogesterone Acetate (JMF-M) in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Hellenic Cooperative Oncology Group Study

1999

D. Bafaloukos
G. Aravantinos
George Samonis
G. Katsifis
C. Bakoyiannis
D. Skarlos
P. Kosmidis

Twenty-three patients with advanced or recurrent endometrial carcinoma entered a prospective study of chemotherapy which consisted of carboplatin (300 mg/m2), methotrexate (30 mg/m2

Keywords:

Carcinoma
Carboplatin
Immunology
Fluorouracil
Cancer
Cancer research
Medroxyprogesterone
Methotrexate
Medicine
Internal medicine
Endocrinology
Medroxyprogesterone acetate
Chemotherapy
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations